E

Emergent Biosolutions

D
EBS
USD
0.13
(1.8868%)
Pre Open
1.00000
Volume
1.5
EPS
-
Div Yield
-0.625668
P/E
371,404,500.48
Market Cap
Today
1.8868%
1 Week
-7.874%
1 Month
-42.031%
6 Months
185.366%
12 Months
86.454%
Year To Date
191.286%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
BX
BX
4.71
(3.0389%)
USD
ICE
ICE
-2.297
(-1.4251%)
USD
N
NDAQ
1.39
(1.9067%)
USD
CME
CME
-1.56
(-0.7212%)
USD
N
NMR
0.145
(2.6952%)
USD
SCHW
SCHW
1.19
(1.872%)
USD
I
IBKR
2.31
(1.7745%)
USD

Title:
Emergent Biosolutions

Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN(R) and other commercial products.
Do you need help or have a question?
Contact Us